Waxman Bill Would Alter OTC Ad Rules, Streamline FDA Monograph Authority
This article was originally published in The Tan Sheet
Executive Summary
Democrats are seeking to significantly increase FDA authority over over-the-counter drug monographs and potentially change the face of OTC advertising, prompted by recent high-profile concerns over pediatric cough/cold medications